Searched for: in-biosketch:yes
person:levanm01
A CONTENT ANALYSIS OF VIDEO-BASED EDUCATIONAL MATERIALS FOR LIVER TRANSPLANT PATIENTS THROUGH THE LENSES OF BOTH PEDAGOGY AND HEALTH EQUITY [Meeting Abstract]
Rajpal, Neha; Hamilton, James P.; Levan, Macey L.; Segev, Dorry L.; Strauss, Alexandra T.
ISI:000870796603205
ISSN: 0270-9139
CID: 5480652
Short Report: Evaluating the Effects of Automated Donor Referral Technology on Deceased Donor Referrals
Levan, Macey L; Trahan, Chad; Klitenic, Samantha B; Hewlett, Jonathan; Strout, Tyler; Levan, Michael A; Vanterpool, Karen B; Segev, Dorry L; Adams, Bradley L; Massie, Allan B; Niles, Patricia
UNLABELLED:Automation of deceased donor referrals with standardized clinical triggers allows organ procurement organizations to be rapidly aware of medically eligible potential donors without the need for manual reporting and subjective decision-making of otherwise very busy hospital staff. In October 2018, 3 Texas hospitals (pilot hospitals) began using an automated referral system; our goal was to evaluate the impact of this system on eligible donor referral. METHODS/UNASSIGNED:We studied ventilated referrals (n = 28 034) in a single organ procurement organization from January 2015 to March 2021. We estimated the change in referral rate in the 3 pilot hospitals due to the automated referral system using a difference-in-differences analysis with Poisson regression. RESULTS/UNASSIGNED:). CONCLUSIONS/UNASSIGNED:Following deployment of an automated referral system that did not require any actions by the referring hospital, referrals, authorizations, and organ donors increased substantially in the 3 pilot hospitals. Broader deployment of automated referral systems may lead to increases in the deceased donor pool.
PMCID:10109458
PMID: 37077729
ISSN: 2373-8731
CID: 5466242
6-month antibody kinetics and durability after four doses of a SARS-CoV-2 vaccine in solid organ transplant recipients [Letter]
Mitchell, Jonathan; Chiang, Teresa Py; Alejo, Jennifer L; Kim, Jake D; Chang, Amy; Abedon, Aura T; Avery, Robin K; Tobian, Aaron A R; Levan, Macey L; Warren, Daniel S; Garonzik-Wang, Jacqueline M; Segev, Dorry L; Massie, Allan B; Werbel, William A
PMID: 36437691
ISSN: 1399-0012
CID: 5383462
Public Perceptions and Information Needs of VCA Transplantation and Donation: A Mixed Methods Study
Ferzola, Alexander; Uriarte, Jefferson; Sung, Hannah C; Anderson, Naomi; Sidoti, Carolyn; Van Pilsum Rasmussen, Sarah E; Downey, Max; Vanterpool, Karen B; Langlee, Whitney; Klitenic, Samantha; Young, Lisa; Cooney, Carisa M; Johnson, Ieesha; Coleman, Allison; Shores, Jaimie T; Segev, Dorry L; Brandacher, Gerald; Gordon, Elisa J; Levan, Macey L
Vascularized Composite Allotransplantation (VCA) involves transplantation of multiple tissues from a donor to a recipient (e.g., skin, muscle, bone). Little is known about the US public's perceptions of and attitudes toward VCA organ donation. This multi-site, cross-sectional, mixed methods study involved focus groups and surveys to assess members of the general public's attitudes about VCA, and willingness and barriers to donate VCA organs. Qualitative data were analyzed by thematic analysis; quantitative data were analyzed by descriptive statistics. In focus groups (n = 6, 42 participants), most participants were female (57%) and Black (62%) with mean age of 42.6 years. Three main themes emerged: 1) awareness and perceptions of VCA, 2) purpose of VCA donation, 3) and barriers to VCA donation. Participants had heard little about VCA and sought information about VCA donation. Participants perceived VCA as challenging their concepts of "normality" and voiced concerns that VCA would create "Frankenstein[s]." Barriers to VCA donation included disruptions to end-of-life arrangements and information gaps regarding the donation process. Participants reported moderate to high willingness to donate their hands (69%) and face (50%) Public education efforts should address the specific needs and concerns of the public to facilitate VCA donation and family authorization.
PMCID:9701711
PMID: 36451683
ISSN: 1432-2277
CID: 5382812
Information needs and development of a question prompt sheet for upper extremity vascularized composite allotransplantation: A mixed methods study
Gacki-Smith, Jessica; Kuramitsu, Brianna R; Downey, Max; Vanterpool, Karen B; Nordstrom, Michelle J; Luken, Michelle; Riggleman, Tiffany; Altema, Withney; Fichter, Shannon; Cooney, Carisa M; Dumanian, Greg A; Jensen, Sally E; Brandacher, Gerald; Tintle, Scott; Levan, Macey; Gordon, Elisa J
Background/UNASSIGNED:People with upper extremity (UE) amputations report receiving insufficient information about treatment options. Furthermore, patients commonly report not knowing what questions to ask providers. A question prompt sheet (QPS), or list of questions, can support patient-centered care by empowering patients to ask questions important to them, promoting patient-provider communication, and increasing patient knowledge. This study assessed information needs among people with UE amputations about UE vascularized composite allotransplantation (VCA) and developed a UE VCA-QPS. Methods/UNASSIGNED:This multi-site, cross-sectional, mixed-methods study involved in-depth and semi-structured interviews with people with UE amputations to assess information needs and develop a UE VCA-QPS. Qualitative data were analyzed by thematic analysis; quantitative data were analyzed by descriptive statistics. The initial UE VCA-QPS included 130 items across 18 topics. Results/UNASSIGNED:Eighty-nine people with UE amputations participated. Most were male (73%), had a mean age of 46 years, and had a unilateral (84%) and below-elbow amputation (56%). Participants desired information about UE VCA eligibility, evaluation process, surgery, risks, rehabilitation, and functional outcomes. After refinement, the final UE VCA-QPS included 35 items, across 9 topics. All items were written at a ≤ 6th grade reading level. Most semi-structured interview participants (86%) reported being 'completely' or 'very' likely to use a UE VCA-QPS. Conclusion/UNASSIGNED:People with UE amputations have extensive information needs about UE VCA. The UE VCA-QPS aims to address patients' information needs and foster patient-centered care. Future research should assess whether the UE VCA-QPS facilitates patient-provider discussion and informed decision-making for UE VCA.
PMCID:9484522
PMID: 36132190
ISSN: 1664-1078
CID: 5335492
Maximizing the use of potential donors through increased rates of family approach for authorization
Levan, Macey L; Massie, Allan B; Trahan, Chad; Hewlett, Jonathan; Strout, Tyler; Klitenic, Samantha B; Vanterpool, Karen B; Segev, Dorry L; Adams, Bradley L; Niles, Patricia
In the United States, a small proportion of potential deceased organ donor referrals lead to donation and recovery. Understanding variation in the processes involved between organ procurement organizations (OPOs) may help increase deceased donation and reduce the organ shortage. We studied 103 923 referrals from 10 OPOs from 2018 to 2019, of which 14.4% led to approach for authorization, 8.2% led to authorization, 5.1% led to organ recovery, and 4.8% led to transplantation. First-person authorization (FPA) was associated with threefold higher odds of donation (OR = 2.83 3.02 3.22 , p < .001). Female referrals had 11% lower odds of approach; when approached, Black and Hispanic referrals had 46% and 35% lower odds of authorization, respectively (all p < .001). There was substantial OPO-level variation in rates of approach, authorization, and organ recovery, which persisted after adjusting for age, sex, race, and FPA status. An OPO's relative rate of approach correlated strongly with its relative rate of donation among all referrals (Ï = 0.43). Correlation between an individual OPO's authorization rate among approached families, and overall rate of donation, was negative, suggesting that high authorization rates may be the result of selective approach practices. Therefore, approaching a higher proportion of families for authorization may lead to higher donation rates.
PMID: 36062407
ISSN: 1600-6143
CID: 5336932
Antibody response to a third dose of SARS-CoV-2 vaccine in heart and lung transplant recipients [Letter]
Alejo, Jennifer L; Ruck, Jessica M; Chiang, Teresa P Y; Abedon, Aura T; Kim, Jake D; Avery, Robin K; Tobian, Aaron A R; Warren, Daniel S; Levan, Macey L; Massie, Allan B; Garonzik-Wang, Jacqueline M; Segev, Dorry L; Werbel, William A
PMID: 36073912
ISSN: 1399-0012
CID: 5332532
Improved humoral immunogenicity with mRNA-1273 versus BNT162b2 as third vaccine dose among solid organ transplant recipients seronegative after two BNT162b2 doses [Letter]
Chang, Amy; Chiang, Teresa Py; Kim, Jake D; Mitchell, Jonathan; Alejo, Jennifer L; Jefferis, Alexa A; Avery, Robin K; Tobian, Aaron A R; Levan, Macey L; Warren, Daniel S; Garonzik-Wang, Jacqueline M; Massie, Allan B; Segev, Dorry L; Werbel, William A
PMID: 35670813
ISSN: 1399-0012
CID: 5283132
Immunogenicity of Ad26.COV2.S prime and two subsequent doses of mRNA SARS-CoV-2 vaccines in solid organ transplant recipients: A case series [Letter]
Chang, Amy; Mitchell, Jonathan; Alejo, Jennifer L; Chiang, Teresa P Y; Abedon, Aura T; Kim, Jake D; Avery, Robin K; Tobian, Aaron A R; Levan, Macey L; Warren, Daniel S; Garonzik-Wang, Jacqueline M; Massie, Allan B; Segev, Dorry L; Werbel, William A
PMID: 35822545
ISSN: 1399-0012
CID: 5279872
Predicting a Positive Antibody Response After 2 SARS-CoV-2 mRNA Vaccines in Transplant Recipients: A Machine Learning Approach With External Validation
Alejo, Jennifer L; Mitchell, Jonathan; Chiang, Teresa P-Y; Chang, Amy; Abedon, Aura T; Werbel, William A; Boyarsky, Brian J; Zeiser, Laura B; Avery, Robin K; Tobian, Aaron A R; Levan, Macey L; Warren, Daniel S; Massie, Allan B; Moore, Linda W; Guha, Ashrith; Huang, Howard J; Knight, Richard J; Gaber, Ahmed Osama; Ghobrial, Rafik Mark; Garonzik-Wang, Jacqueline M; Segev, Dorry L; Bae, Sunjae
BACKGROUND:Solid organ transplant recipients (SOTRs) are less likely to mount an antibody response to SARS-CoV-2 mRNA vaccines. Understanding risk factors for impaired vaccine response can guide strategies for antibody testing and additional vaccine dose recommendations. METHODS:Using a nationwide observational cohort of 1031 SOTRs, we created a machine learning model to explore, identify, rank, and quantify the association of 19 clinical factors with antibody responses to 2 doses of SARS-CoV-2 mRNA vaccines. External validation of the model was performed using a cohort of 512 SOTRs at Houston Methodist Hospital. RESULTS:Mycophenolate mofetil use, a shorter time since transplant, and older age were the strongest predictors of a negative antibody response, collectively contributing to 76% of the model's prediction performance. Other clinical factors, including transplanted organ, vaccine type (mRNA-1273 versus BNT162b2), sex, race, and other immunosuppressants, showed comparatively weaker associations with an antibody response. This model showed moderate prediction performance, with an area under the receiver operating characteristic curve of 0.79 in our cohort and 0.67 in the external validation cohort. An online calculator based on our prediction model is available at http://transplantmodels.com/covidvaccine/. CONCLUSIONS:Our machine learning model helps understand which transplant patients need closer follow-up and additional doses of vaccine to achieve protective immunity. The online calculator based on this model can be incorporated into transplant providers' practice to facilitate patient-centric, precision risk stratification and inform vaccination strategies among SOTRs.
PMID: 35859275
ISSN: 1534-6080
CID: 5279212